Revolution Medicines, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 4.5M | 4.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -4.5M | -4.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 344.0M | 292.6M | 262.5M | 224.1M | 205.7M | 188.1M | 151.8M | 134.9M |
| Operating Expenses | 440.7M | 356.9M | 315.3M | 264.7M | 240.8M | 216.3M | 175.7M | 156.6M |
| Operating Income | -445.2M | -361.6M | -315.3M | -264.7M | -240.8M | -216.3M | -175.7M | -156.6M |
| Other Income / Gains | -8.6M | -3.3M | 10.1M | 16.9M | 27.3M | 21.0M | 19.4M | 23.4M |
| Net Income | -453.8M | -364.9M | -305.2M | -247.8M | -213.4M | -194.6M | -156.3M | -133.2M |
| EPS (Diluted) | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 101.3M | 64.3M | 52.8M | 40.6M | 35.0M | 28.2M | 24.0M | 21.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 101.3M | 64.3M | 52.8M | 40.6M | 35.0M | 28.2M | 24.0M | 21.7M |
| Other Expenses | -4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 445.2M | 361.6M | 315.3M | 264.7M | 240.8M | 216.3M | 175.7M | 156.6M |
| Interest Income | 19.5M | 21.3M | 22.1M | 22.4M | 24.9M | 21.2M | 20.4M | 21.5M |
| Interest Expense | 12.2M | 11.9M | 11.4M | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 4.5M | 4.7M | 4.3M | 3.8M | 3.7M | 3.4M | 2.9M | 2.8M |
| Ebitda | -440.7M | -348.3M | -289.4M | -260.9M | -237.0M | -212.9M | -153.4M | -153.8M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Income Before Tax | -453.8M | -364.9M | -305.2M | -247.8M | -213.4M | -195.3M | -156.3M | -133.2M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | -753K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Epsdiluted | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 | -1.13 | -0.94 | -0.81 |
| Weighted Average Shs Out | 198.1M | 190.1M | 189.2M | 188.1M | 188.1M | 167.7M | 166.8M | 165.1M |
| Weighted Average Shs Out Dil | 198.1M | 190.1M | 189.2M | 188.1M | 188.1M | 167.7M | 166.8M | 165.1M |